期刊文献+

全身炎症反应综合征中血浆尿激酶型纤溶酶原激活物及其受体的表达 被引量:7

The expression of uPA and uPAR in patients with systemic inflammatory response syndrome
原文传递
导出
摘要 目的探讨upA,uPAR与D-D,IL-6及TNF-α之间的关系及其在SIRS中的作用。方法采用前瞻性、临床病例对照研究,病例的收集均来源于武汉市中心医院2008年1月至2010年1月年龄〉55岁的就诊患者,标本的采集均为清晨空腹静脉血清,检测全身炎症反应综合征(SIRS)患者血中尿激酶型纤溶酶原激活物(uPA)及其受体(uPAR)、D-二聚体(D-D)、白细胞介素6(IL-6)和肿瘤坏死因子(TNF-d)含量。按SIRS诊断标准分为SIRS组:50例来源于重症医学科;非SIRS组35例来源于内科病房;另选30例体检科体检者作为健康对照组,均需排除:(1)孕产妇;(2)恶性肿瘤;(3)转入ICU后7d内死亡;(4)心肺复苏术后;(5)既往有血液系统疾病;(6)人住ICU时即有SIRS的患者。采用双抗体夹心酶联免疫吸附法(ELISA)测定血中uPA,uPAR,D-D,IL-6及TNF-α含量。数据均采用SPSS17.0统计学软件进行分析:正态分布的计量资料以均数±标准差(x±s)表示,独立样本t检验进行分析;非正态分布的计量资料以中位数表示,Mann-Whitney秩和检验;相关性分析采用Spearman秩相关检验;以24h血uPA、uPAR、IL-6和TNF-α作受试者工作特征曲线(ROC曲线),比较SIRS患者血uPA,uPAR,IL-6和TNF-α含量诊断MODS的应用价值。结果SIRS组患者血uPA,uPAR,D-D,IL-6及TNF-α含量较非SIRS组和健康对照组均显著升高(均P〈0.01)。uPA与IL-6、TNF-仪不相关,uPAR与IL-6,TNF-α呈正相关(分别为r=0.395,P:0.004;,=0.606,P〈0.01)。以uPA,uPAR,IL-6及TNF-α诊断MODS做ROC曲线,ROC曲线下面积(AUROC)分别为0.59,0.76,0.86,0.83。结论uPA和uPAR参与了SIRS患者凝血功能障碍的过程,但在SIRS中起作用的途径机制并不完全相同。uPAR在SIRS向MODS的发展过程中起着一定作用。 Objective To test plasma levels of uPA, uPAR , D-dimer, IL-6 and TNF-α, andobserve the relationships between uPA, uPAR and D-dimer, IL-6 , TNF-αin patients with SIRS. Methods A prospective, clinical case-control study was adopted. Cases were collected from our hospital in January 2008 to January 2010, and all were 〉 55 years of age. Venous blood samples were collected via routine venipuncture. Eighty-five patients were divided into two groups according to diagnostic criteria of SIRS : SIRS group collected from Intensive Care Unit (n = 50) and non SIRS group collected from medical ward (n = 35). The control group comprised 30 unrelated healthy blood donors who visited the General Health Checkup Division at our hospital. Patients with (1) pregnant women; (2) cancer; (3) died after admitted into ICU in 7 days ; (4) after cardiopulmonary resuscitation ; ( 5 ) with previous blood system diseases ; ( 6 ) patients with SIRS before admitted into ICU were excluded from the study, uPA , uPAR, D-D, IL-6 and TNF-α in blood were detected by commercial enzyme-linked immunosorbent assay (ELISA) kits. The data was analyzed using SPSS versionlT. 0. Data accorded with normal distribution of measurement was expressed as mean ± standard, and analyzed by independent-samples t test; non-normal distribution of measurement data, expressed by median, was analyzed with Mann-Whitney test. Relationships between plasma levels of uPA, uPAR and D-dimer, IL-6 TNF-α were analyzed using Spearman rank correlation test. To compare with blood level of uPA, uPAR, IL-6 and TNF-α in SIRS patients in the application of diagnostic value of MODS, we constructed the receiver operating characteristic curve (ROC curve) for blood levels of uPA, uPAR, IL-6 and TNF-α in 24 h. Results The plasma levels of uPA , uPAR, D-dimer, IL-6 and TNF-αin patients of SIRS were obviously higher compared with non-SIRS and normal controls ( all P 〈 0. 01 ). Correlation analysis showed that there was positive correlation between uPAR level and IL-6 level (r = 0. 395, P = 0. 004) ; there was positive correlation between uPAR level and TNF-alevel ( r = 0. 606, P 〈 0. 01 ). There was no correlation between uPAR level and D-dimer level ( r = - 0. 069, P = 0. 632). There was no correlation between uPA level and D-dimer, IL-6 or TNF-α (all P 〉 0. 05). There ROC curve were made based on the abilities of uPAR, D-dimer, IL-6 and TNF-cdevels in 24 hours to diagnose MODS, and the ROC areas under the curves were 0.76, 0. 58, 0. 86, 0. 83 respectively. Conclusions These results demonstrate that uPA and uPAR play a major contributory role in patients with SIRS in the process of coagulation disorders, but the mechanism in SIRS is not the same. uPAR may play a central rolein the development of SIRS to MODS.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2011年第10期1079-1083,共5页 Chinese Journal of Emergency Medicine
基金 武汉市卫生局临床医学科研资助项目(WX08D10)
关键词 全身炎症反应综合征 多器官功能障碍综合征 尿激酶型纤溶酶原激活物 尿激酶 型纤溶酶原激活物受体 D-二聚体 白细胞介素6 肿瘤坏死因子Α 凝血功能 Systemic inflammatory response syndrome Multiple organ dysfunction syndrome Urokinase type plasminogen activator Urokinase type plasminogen activator receptor D-dimer Interleukin-6 Tumor necrosis factor-alpha Coagulant function
  • 相关文献

参考文献20

  • 1Asakura H, Wada H, Okamoto K, et al. Evaluation of haemostatic molecular markers for diagonosis of disseminated intravascular coagulation in patients with infections [ J ]. Thromb Haemost, 2006, 95 (2): 282-287.
  • 2Nielsen JS, Larsson A, Rix T, et al. The effect of activated protein C on plasma cytokine levels in a porcin model of acute endotoxemia [J]. Intensive Care Med, 2007, 33 (6) : 1085-1093.
  • 3Conway EM, Wouwer M, Pollefeyt S, et al. The lectin-like domain of thrombomodulin confersprotection from neutrophil-2 mediated tissue damage by suppressing adhesionmolecule expression via nuclear factor kappa B and mitogen-activated protein kinase pathways [J]. J Exp Med, 2002, 196 (5) : 565-577.
  • 4孙显路,孙仁寿,李玉军,张顺,吴力群.尿激酶型纤溶酶原激活物及其受体表达与胰腺癌浸润和转移的关系[J].青岛大学医学院学报,2003,39(3):244-245. 被引量:5
  • 5American college of chest physicians/ society of critical care medicine consensus conference. Definitions for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis [J]. Critical Care Med, 1992, 20 (6) : 864-874.
  • 6王可富,田锁臣.多器官功能障碍综合征[M]//王春亭,现代重症抢救技术.北京:人民卫生出版社,2007:13-23.
  • 7祝益民.危重患儿并发全身炎症反应综合征的认识[J].中华急诊医学杂志,2009,18(6):671-672. 被引量:3
  • 8王荃,钱素云.生理性抗凝机制在脓毒症中的研究进展[J].国外医学(儿科学分册),2005,32(2):68-71. 被引量:8
  • 9Lowe Gd. How to search for the role and prevalence of defective fibrinolytic states as triggers of myocardial infaretion. The haemostasis epidrniologist' s view [ J]. Ital Heart J, 2001, 2 (9) : 656-657.
  • 10Mondino A, Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology [J]. Trends Immunol, 2004, 25 (8) : 450-455.

二级参考文献50

  • 1Moss M, Martin GS. A global perspective on the epidemiology of sepsis [J]. Intensive Care Med,2004, 30(4) :527-529.
  • 2Nasraway SA. The problems and challenges of immunotheraphy in sepsis [J]. Chest,2003,123(5 Suppl) :451-459.
  • 3张文彤.多重线性回归模型[M].//张文彤.SPSS统计分析高级教程.北京:高等教育出版社,2004:106-111.
  • 4Napolitano LM. Immune stimulation in sepsis: to be or not to be? [ J ]. Chest,2005,127(6) : 1882-1885.
  • 5Ren Y, Wang JD, Xia J, et al. The alterations of mouse plasma proteins during septic development[J]. J proteome Res,2007,6(7) :2812-2821.
  • 6Carrigan SD, Scott G, Tabrizian M. Toward resolving the challenges of sepsis diagnosis[J]. Clinical Chemistry,2004,50(8) : 1301-1314.
  • 7Calvano SE,Xiao WZ,Richards DR,et al.A network-based analysis of systemic inflammation in humans[ J ]. Nature, 2005,437 ( 7061 ) : 1032-1037.
  • 8Pachot A, Monneret G, Voirin N, et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock[J]. Clinical Immunology, 2005,114 ( 1 ) : 61-69.
  • 9Payen D, Faivre V, Lukaszewicz AC, et al. Assessment of immtmological status in the critically ill[ J ]. Minerva Anestesiol,2000,66(10) : 757-763.
  • 10Saban MR, Hellmich H, Nguyen N, et al. Time course of LPS-induced gene exprseeion in a mouse model of genitourinary inflammation [ J ]. Physiol Genomics,2001,5(3) : 147-160.

共引文献50

同被引文献81

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部